The role of physical activity in improving the condition of patients with COPD (review article)
https://doi.org/10.36604/1998-5029-2024-91-134-148
Abstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death, accounting for approximately 6% of all deaths, confirming its relevance and making it a subject of close attention of the global medical community. The integration of physical activity (PA) into the regimen of patients with COPD plays a key role in maintaining their health and improving quality of life. However, despite the inclusion of PA in pulmonary rehabilitation programs having become a routine method, questions remain today about establishing several universal formats of rehabilitation measures on the one hand and personalization on the other. This review is based on the analysis of relevant publications obtained as a result of selective literature search using the following keywords: COPD, quality of life, physical activity, pulmonary rehabilitation. Articles indicating the effects of PA as one of the main components of comprehensive pulmonary rehabilitation in patients with COPD are considered. Tools for assessing PA, its impact on the frequency of disease exacerbations, and mortality are discussed. Results confirming the importance and necessity of physical exercises as part of pulmonary rehabilitation are presented, as well as modern problems faced by specialists conducting pulmonary rehabilitation and their potential solutions.
About the Authors
I. V. Demko
Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation;
Regional State Budgetary Healthcare Institution «Regional Clinical Hospital»
Russian Federation
Russian Federation
Irina V. Demko, MD, PhD, DSc (Med.), Professor, Head of Department of Hospital Therapy and Immunology with Postgraduate Education Course, 1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022;
Head of Pulmonary Allergology Сenter, 3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
M. G. Mamaeva
Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation;
Regional State Budgetary Healthcare Institution «Regional Clinical Hospital»
Russian Federation
Russian Federation
Marina G. Mamaeva, MD, PhD (Med.), Associate Professor of Department of Hospital Therapy and Immunology with Postgraduate Education Course, 1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022;
Pulmonologist of Department of Pulmonology, 3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
N. V. Gordeeva
Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation;
Regional State Budgetary Healthcare Institution «Regional Clinical Hospital»
Russian Federation
Russian Federation
Natalya V. Gordeeva, MD, PhD (Med.), Associate Professor of Department of Hospital Therapy and Immunology with Postgraduate Education Course,
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022;
Pulmonologist of Department of Pulmonology, 3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
V. S. Alekseeva
Federal State Budgetary Educational Institution of Higher Education «Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Valeriia S. Alekseeva, 6th year student of Medical Faculty,
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
References
1. Global initiative for chronic obstructive lung disease (GOLD). (Update 2023). Available at: https://goldcopd.org/2023-gold-report-2
2. World Health Organization. The top 10 causes of death. (Update 09.12.2020). Available at: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death
3. López-Campos J.L., Tan W., Soriano J.B. Global burden of COPD. Respirology 2016; 21(1): 14–23. https://doi.org/10.1111/resp.12660
4. Martinez F.J., Mannino D., Leidy N.K., Malley K.G., Bacci E.D., Barr R.G., Bowler R.P., Han M.K., Houfek J.F., Make B., Meldrum C.A., Rennard S., Thomashow B., Walsh J., Yawn B.P. A new approach for identifying patients with undiagnosed chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2017; 195(6): 748–756. https://doi.org/10.1164/rccm.201603-0622OC
5. Kulik E.G., Pavlenko V.I., Naryshkina S.V. [Clinical and functional portrait of a patient with chronic obstructive pulmonary disease phenotype without frequent exacerbations]. Vestnik sovremennoj klinicheskoj mediciny = The Bulletin of Contemporary Clinical Medicine 2022; 15(1): 62–67 (in Russian). https://doi.org/10.20969/VSKM.2022.15(1).62-67
6. Rodriguez-Roisin R., Han M.K., Vestbo J., Wedzicha J.A., Woodruff P.G., Martinez F.J. Chronic respiratory symptoms with normal spirometry: a reliable clinical entity? Am. J. Respir. Crit. Care Med. 2016; 195(1): 17–22. https://doi.org/10.1164/rccm.201607-1376PP
7. Watz H., Pitta F., Rochester C.L., Garcia-Aymerich J., ZuWallack R., Troosters T., Vaes A.W., Puhan M.A., Jehn M., Polkey M.I., Vogiatzis I., Clini E.M., Toth M., Gimeno-Santos E., Waschki B., Esteban C., Hayot M., Casaburi R., Porszasz J., McAuley E., Singh S.J., Langer D., Wouters E.F.M., Magnussen H., Spruit M.A. An official european respiratory society statement on physical activity in COPD. Eur. Respir. J. 2014; 44(6): 1521–1537. https://doi.org/10.1183/09031936.00046814
8. Núñez-Cortés R., Padilla-Acevedo P., Vergara-Peña F., Mollà-Casanova S., Espinoza-Bravo C., Torres-Castro R., Cruz-Montecinos C. Clinical assessment of balance and functional impairments in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. ERJ Open Res. 2022; 8(4): 00164-2022. https://doi.org/10.1183/23120541.00164-2022
9. Jehn M., Schindler C., Meyer A., Tamm M., Schmidt-Trucksäss A.,Stolz D. Daily walking intensity as a predictor of quality of life in patients with chronic obstructive pulmonary disease. Med. Sci. Sports Exerc. 2012; 44(7): 1212-8. https://doi.org/10.1249/MSS.0b013e318249d8d8
10. Van Remoortel H., Hornikx M., Demeyer H., Langer D., Burtin C., Decramer M., Gosselink R., Janssens W., Troosters T. Daily physical activity in subjects with newly diagnosed COPD. Thorax 2013; 68(10): 962–963. https://doi.org/10.1136/thoraxjnl-2013-203534
11. Gimeno-Santos E., Balcells E., Rodríguez D.A., Farrero E., de Batlle J., Benet M., Ferrer A., Barberà J.A., Gea J., Rodriguez-Roisin R., Antó J.M., Garcia-Aymerich J. Physical activity in COPD patients: patterns and bouts. Eur. Respir. J. 2013; 42(4): 993–1002. https://doi.org/10.1183/09031936.00101512
12. Gea J., Pascual S., Casadevall C., Orozco-Levi M., Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J. Thorac. Dis. 2015; 7(10): E418–E438. https://doi.org/10.3978/j.issn.2072-1439.2015.08.04
13. Witt L.J., Wroblewski K.E., Pinto J.M., Wang E., McClintock M.K., Dale W., White S.R., PressV.G., HuisinghScheetz M. Beyond the lung: geriatric conditions afflict community-dwelling older adults with self-reported chronic obstructive pulmonary disease. Front. Med. 2022; 9: 814606. https://doi.org/10.3389/fmed.2022.814606
14. Ebadi Z., Goërtz Y.M.J., Van Herck M., Janssen D.J.A., Spruit M.A., Burtin C.,Thong M.S.Y., Muris J., Otker J., Looijmans M.,Vlasblom C., Bastiaansen J., Prins J., Wouters E.F.M., Vercoulen J.H., Peters J.B. The prevalence and related factors of fatigue in patients with COPD: a systematic review. Eur. Respir. Rev. 2021; 30(160): 200298. https://doi.org/10.1183/16000617.0298-2020
15. O’Donnell D.E., Milne K.M., James M.D., de Torres J.P., Neder J.A. Dyspnea in COPD: new mechanistic insights and management implications. Adv. Ther. 2020; 37(1): 41–60. https://doi.org/10.1007/s12325-019-01128-9
16. Carl J., Schultz K., Janssens T., von Leupoldt A., Pfeifer K., Geidl W. The, “can do, do do” concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms. Respir. Res. 2021; 22(1): 260. https://doi.org/10.1186/s12931-021-01854-1
17. Sievi N.A., Brack T., Brutsche M.H., Frey M., Irani S.,Leuppi J.D., Thurnheer R., Kohler M., Clarenbach C.F. Physical activity declines in COPD while exercise capacity remains stable: a longitudinal study over 5 years. Respir. Med. 2018; 141: 1–6. https://doi.org/10.1016/j.rmed.2018.06.013
18. Sritharan S.S., Ostergaard E.B., Callesen J., Elkjaer M., Sand L.,Hilberg O., Skaarup S.H., Lokke A. Barriers toward physical activity in COPD: a quantitative cross-sectional. Quest-Based Study. COPD 2021; 18(3): 272–280. https://doi.org/10.1080/15412555.2021.1922371
19. Kozlov E.V. [Anxiety and depressive disorders with comorbidity of chronic obstructive pulmonary disease and arterial hypertension]. Sibirskoe medicinskoe obozrenie = Siberian Medical Review 2014; 1(85): 19–25 (in Russian).
20. Celli B., Blasi F., Gaga M., Singh D., Vogelmeier C., Pegoraro V., Caputo N., Agusti A. Perception of symptoms and quality of life – comparison of patients' and physicians' views in the COPD MIRROR study. Int. J. Chron. Obstruct. Pulmon. Dis. 2017; 12: 2189–2196. https://doi.org/10.2147/COPD.S136711
21. Xiang X., Huang L., Fang Y., Cai S., Zhang M. Physical activity and chronic obstructive pulmonary disease: a scoping review. BMC Pulm. Med. 2022; 22(1): 301. https://doi.org/10.1186/s12890-022-02099-4
22. Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., Yates J.C., Vestbo J. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775–789. https://doi.org/10.1056/NEJMoa063070
23. Wise R.A., Anzueto A., Cotton D., Dahl R., Devins T., Disse B., Dusser D., Joseph E., Kattenbeck S., KoenenBergmann M., Pledger G., Calverley P. TIOSPIR Investigators. Tiotropium Respimat inhaler and the risk of death in COPD. N. Engl. J. Med. 2013; 369(16): 1491–1501. https://doi.org/10.1056/NEJMoa1303342
24. McCarthy B., Casey D., Devane D., Murphy K., Murphy E., Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015; 2(2): CD003793. https://doi.org/10.1002/14651858.CD003793.pub3
25. Spruit M.A., Singh S.J., Garvey C., ZuWallack R., Nici L., Rochester C., Hill K., Holland A.E., Lareau S.C., Man W.D.-C., Pitta F., Sewell L., Raskin J., Bourbeau J., Crouch R., Franssen F.M.E., Casaburi R., Vercoulen J.H.,Vogiatzis I., Gosselink R., Clini E.M., Effing T.W., Maltais F., van der Palen J., Troosters T., Janssen D.J.A., Collins E., Garcia-Aymerich J., Brooks D., Fahy B.F., Puhan M.A., Hoogendoorn M., Garrod R., Schols A.M.W.J., Carlin B., Benzo R., Meek P., Morgan M., Rutten-van Mölken M.P.M., Ries A.L., Make B., Goldstein R.S., Dowson C.A., Brozek J.L., Donner C.F., Wouters E.F.M. ATS/ERS task force on pulmonary rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care. Med. 2013; 188(8): E13–E64. https://doi.org/10.1164/rccm.201309-1634ST
26. Wshah A., Selzler A.M., Hill K., Brooks D., Goldstein R. Embedding a behavior change program designed to reduce sedentary time within a pulmonary rehabilitation program is feasible in people with COPD. J. Cardiopulm. Rehabil. Prev. 2022; 42(1): 45–51. https://doi.org/10.1097/HCR.0000000000000624
27. Rodrigues S. de O., da Cunha C.M.C., Soares G.M.V., Silva P.L., Silva A.R., Gonçalves-de-Albuquerque C.F. Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease. Pharmaceuticals (Basel) 2021; 14(10): 979. https://doi.org/10.3390/ph14100979
28. Marchetti N., Kaplan A. Dyspnea and hyperinflation in chronic obstructive pulmonary disease: impact on physical activity. Cleve Clin. J. Med. 2018; 85(2): Suppl 1: S3–S10. https://doi.org/10.3949/ccjm.85.s1.02
29. McCarthy B., Casey D., Devane D., Murphy K., Murphy E., Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2015; 2015(2): CD003793. https://doi.org/10.1002/14651858.CD003793.pub3
30. Stevens D., Andreou P., Rainham D. Environmental correlates of physical activity, sedentary behavior, and selfrated health in chronic obstructive pulmonary disease. J. Cardiopulm. Rehabil. Prev. 2022; 42(3): 190–195. https://doi.org/10.1097/HCR.0000000000000628
31. Yu T., Ter Riet G., Puhan M.A., Frei A. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Prim. Care. Respir. Med. 2017; 27(1): 36. https://doi.org/10.1038/s41533-017-0034-x
32. Duenas-Espin I., Demeyer H., Gimeno-Santos E., Polkey M.I., Hopkinson N.S., Rabinovich R.A., Dobbels F., Karlsson N., Troosters T., Garcia-Aymerich J. Depression symptoms reduce physical activity in COPD patients: a prospective multicenter study. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11: 1287–1295. https://doi.org/10.2147/COPD.S101459
33. Vogelmeier C.F., Román-Rodríguez M., Singh D., Han M.K., Rodríguez-Roisin R., Ferguson G.T. Goals of COPD treatment: Focus on symptoms and exacerbations. Respir. Med. 2020; 166: 105938. https://doi.org/10.1016/j.rmed.2020.105938
34. Garcia-Rio F., Rojo B., Casitas R., Lores V., Madero R., Romero D., Galera R., Villasante C. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012; 142(2): 338–346. https://doi.org/10.1378/chest.11-2014
35. Demeyer H., Mohan D., Burtin C., Vaes A.W., Heasley M., Bowler R.P., Casaburi R., Cooper C.B., Corriol-Rohou S., Frei A., Hamilton A., Hopkinson N.S., Karlsson N., Man W.D., Moy M.L., Pitta F., Polkey M.I., Puhan M., Rennard S.I., Rochester C.L., Rossiter H.B., Sciurba F., Singh S., Tal-Singer R., Vogiatzis I., Watz H., Lummel R.V., Wyatt J., Merrill D.D., Spruit M.A., Garcia-Aymerich J., Troosters T. Chronic lung disease biomarker and clinical outcome assessment qualification consortium task force on physical activity. Objectively measured physical activity in patients with COPD: recommendations from an international task force on physical activity. Chronic. Obstr. Pulm. Dis. 2021; 8(4): 528–550. https://doi.org/10.15326/jcopdf.2021.0213
36. Ryrso C.K., Godtfredsen N.S., Kofod L.M., Lavesen M., Mogensen L., Tobberup R., Farver-Vestergaard I., Callesen H.E., Tendal B., Lange P., Iepsen U.W. Lower mortality after early supervised pulmonary rehabilitation following COPDexacerbations: a systematic review and meta-analysis. BMC Pulm. Med. 2018; 18(1): 154. https://doi.org/10.1186/s12890- 018-0718-1
37. Lindenauer P.K., Stefan M.S., Pekow P.S., Mazor K.M., Priya A., Spitzer K.A., Lagu T.C., Pack Q.R., Pinto-Plata V.M., ZuWallack R. Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among medicare beneficiaries. JAMA 2020; 323(18): 1813–1823. https://doi.org/10.1001/jama.2020.4437
38. Nguyen H.Q., Rondinelli J., Harrington A., Desai S., Liu I-L.A., Lee J.S., Gould M.K. Functional status at discharge and 30-day readmission risk in COPD. Respir. Med. 2015; 109(2): 238–246. https://doi.org/10.1016/j.rmed.2014.12.004
39. McKeough Z., Cheng S.W.M., Alison J., Jenkins C., Hamer M., Stamatakis E. Low leisure-based sitting time and being physically active were associated with reduced odds of death and diabetes in people with chronic obstructive pulmonary disease: a cohort study. J. Physiother. 2018; 64(2): 114–120. https://doi.org/10.1016/j.jphys.2018.02.007
40. Shu C.C., Lee J.H., Tsai M.K., Su T.C., Wen C.P. The ability of physical activity in reducing mortality risks and cardiovascular loading and in extending life expectancy in patients with COPD. Sci. Rep. 2021; 11(1): 21674. https://doi.org/10.1038/s41598-021-00728-2
41. Donaire-Gonzalez D., Gimeno-Santos E., Balcells E., de Batlle J., Ramon M.A., Rodriguez E., Farrero E., Benet M., Guerra S., Sauleda J., Ferrer A., Ferrer J., Barberà J.A., Rodriguez-Roisin R., Gea J., Agustí A., Antó J.M., GarciaAymerich J. PAC-COPD Study Group. Benefits of physical activity on COPD hospitalisation depend on intensity. Eur. Respir. J. 2015; 46(5): 1281–1289. https://doi.org/10.1183/13993003.01699-2014
42. Vaes A.W., Garcia-Aymerich J., Marott J.L., Benet M., Groenen M.T.J., Schnohr P., Franssen F.M.E., Vestbo J., Wouters E.F.M., Lange P., Spruit M.A. Changes in physical activity and all-cause mortality in COPD. Eur. Respir. J. 2014; 44(5): 1199–1209. https://doi.org/10.1183/09031936.00023214
43. Waschki B., Kirsten A., Holz O., Müller K.C., Meyer T., Watz H., Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140(2): 331–342. https://doi.org/10.1378/chest.10-2521
44. Ringbaek T.J., Lange P. Outdoor activity and performance status as predictors of survival in hypoxaemic chronic obstructive pulmonary disease (COPD). Clin. Rehabil. 2005; 19(3): 331–338. https://doi.org/10.1191/0269215505cr798oa
45. Wootton S.L., Hill K., Alison J.A., Ng L.W.C., Jenkins S., Eastwood P.R., Hillman D.R., Jenkins C., Spencer L., Cecins N., Straker L., McKeough Z.J. Effects of ground-based walking training on daily physical activity in people with COPD: A randomised controlled trial. Respir. Med. 2017; 132:139–145. https://doi.org/10.1016/j.rmed.2017.10.008
46. Crook S., Busching G., Keusch S., Wieser S., Turk A., Frei M., Puhan M.A., Frei A. The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2018; 13:2199–2206. https://doi.org/10.2147/COPD.S156986
47. Seidel D., Cheung A., Suh E-S., Raste Y., Atakhorrami M., Spruit M.A. Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease. Int. J. Tuberc. Lung Dis. 2012; 16(8):1015–1019. https://doi.org/10.5588/ijtld.12.0050
48. Garcia-Aymerich J., Lange P., Benet M., Schnohr P., Antó J.M. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am. J. Respir. Crit. Care Med. 2007; 175(5):458–463. https:// doi.org/10.1164/rccm.200607-896OC
49. Greening N.J., Williams J.E., Hussain S.F., Harvey-Dunstan T.C., Bankart M.J., Chaplin E.J., Vincent E.E., Chimera R., Morgan M.D., Singh S.J., Steiner M.C. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled. BMG 2014; 349:g84315. https://doi.org/10.1136/bmj.g4315
50. Gloeckl R., Schneeberger T., Jarosch I., Kenn K. Pulmonary rehabilitation and exercise training in chronic obstructive pulmonary disease. Dtsch Arztebl. Int. 2018; 115(8):117–123. https://doi.org/10.3238/arztebl.2018.0117
51. Alison J.A., McKeough Z.J., Johnston K., McNamara R.J., Spencer L.M., Jenkins S.C., Hill C.J., McDonald V.M., Frith P., Cafarella P., Brooke M., Cameron-Tucker H.L., Candy S., Cecins N., ChanA.S.L., Dale M.T., Dowman L.M., Grager C., Halloran S., Jung P., Lee A.L., Leung R., Matulick T., Osadnik C., Roberts M., Walsh J., Wootton S., Holland A.E. Australian and new zealand pulmonary rehabilitation guidelines. Respirology 2017; 22(4):800–819. https://doi.org/10.1111/resp.13025
52. Güell M.R., Cejudo P., Ortega F., Puy M.C., Rodríguez-Trigo G., Pijoan J.I., Martinez-Indart L., Gorostiza A., Bdeir K., Celli B., Galdiz J.B. Benefits of long-term pulmonary rehabilitation maintenance program in patients with severe chronic obstructive pulmonary disease. Three-year follow-up. Am. J. Respir. Crit. Care Med. 2017; 195(5):622–629. https://doi.org/10.1164/rccm.201603-0602OC
53. Frei A., Radtke T., Dalla Lana K., Brun P., Sigrist T., Spielmanns M., Beyer S., Riegler T.F., Büsching G., Spielmanns S., Kunz R., Cerini T., Braun J., Tomonaga Y., Serra-Burriel M., Polhemus A., Puhan M.A. Effectiveness of a longterm home-based exercise training program in patients with COPD after pulmonary rehabilitation a multicenter randomized controlled trial. Chest 2022; 162(6):1277–1286. https://doi.org/10.1016/j.chest.2022.07.026
54. Altenburg W.A., ten Hacken N.H., Bossenbroek L., Kerstjens H.A., de Greef M.H., Wempe J.B. Short- and longterm effects of a physical activity counselling programme in COPD: a randomized controlled trial. Respir. Med. 2015; 109(1):112–121. https://doi.org/10.1016/j.rmed.2014.10.020
55. Stolz D., Boersma W., Blasi F., Louis R., Milenkovic B., Kostikas K., Aerts J.G., Rohde G., Lacoma A., Rakic J., Boeck L., Castellotti P., Scherr A., Marin A., Hertel S., Giersdorf S., Torres A., Welte T., Tamm M. Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 2014; 146(2):328–338. https://doi.org/10.1378/chest.13-1967
56. Watz H., Troosters T., Beeh K.M., Garcia-Aymerich J., Paggiaro P., Molins E., Notari M., Zapata A., Jarreta D., Garcia Gil E. ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2017; 12:2545–2558. https://doi.org/10.2147/COPD.S143488
57. Vasilopoulou M., Papaioannou A.I., Kaltsakas G., Louvaris Z., Chynkiamis N., Spetsioti S., Kortianou E., GenimataS.A., Palamidas A., Kostikas K., Koulouris N.G., Vogiatzis I. Home-based maintenance tele-rehabilitation reduces the risk for acute exacerbations of COPD, hospitalisations and emergency department visits. Eur. Respir. J. 2017; 49(5):1602129. https://doi.org/10.1183/13993003.02129-2016
58. Widyastuti K., Makhabah D.N., Setijadi A.R., Sutanto Y.S., Suradi, Ambrosino N. Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial. Pulmonology 2018; 24(4): 211–218. https://doi.org/10.1016/j.pulmoe.2018.01.006
59. Bentley C.L., Powell L., Potter S., Parker J., Mountain G.A., Bartlett Y.K., Farwer J., O'Connor C., Burns J., Cresswell R.L., Dunn H.D., Hawley M.S. The use of a smartphone app and an activity tracker to promote physical activity in the management of chronic obstructive pulmonary disease: randomized controlled feasibility study. JMIR Mhealth. Uhealth. 2020; 8(6):E16203. https://doi.org/10.2196/16203
60. Qiu S., Cai X., Wang X., He C., Zügel M., Steinacker J.M., Schumann U. Using step counters to promote physical activity and exercise capacity in patients with chronic obstructive pulmonary disease: a meta-analysis. Ther. Adv. Respir. Dis. 2018; 12:1753466618787386. https://doi.org/10.1177/1753466618787386
Review
For citations:
Demko I.V., Mamaeva M.G., Gordeeva N.V., Alekseeva V.S. The role of physical activity in improving the condition of patients with COPD (review article). Bulletin Physiology and Pathology of Respiration. 2024;(91):134-148. (In Russ.) https://doi.org/10.36604/1998-5029-2024-91-134-148
Views:
357
Email this article 